Very recently, it was reported that overexpression of miR-449b in NPC down-regulated TGF-β-induced (TGFβI), a target gene of TGF-β pathway, leading to increased pro-TGF-β1 activation and cisplatin resistance [161]. This evidence concerns the gene TGFB1 and nasopharyngeal carcinoma.